Article
Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
International journal of cancer - 1 Jun 2008
Jeyapalan Jennie N, Mendez-Bermudez Aaron, Zaffaroni Nadia, Dubrova Yuri E, Royle Nicola J
Abstract excerpt
Immortalized and cancer cells maintain their telomeres by activation of a telomere maintenance mechanism (TMM). In approximately 85% of cancers telomerase is activated (TA) but in some tumours, in particular sarcomas, an alternative lengthening of telomeres (ALT) pathway is used. Liposarcomas are the most common soft-tissue sarcoma in adults and they activate ALT or telomerase with equal frequency, however no TMM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
